Covid-19: Brazilian Company To Test Monoclonal Antibody Against The Virus
COVID-19: The National Health Surveillance Agency (Anvisa) has cleared the start of Phase 3 clinical trials with the monoclonal antibody leronlimab against COVID-19. The authorization was announced this Monday (22) by Biomm, the company responsible for marketing the substance in Brazil. The study will be led by the Academic Research Organization (ARO) of Hospital Israelita … Read more